ARTICLE | Clinical News
Tamiflu oseltamivir regulatory update
February 6, 2006 8:00 AM UTC
EMEA approved a Type II variation application for Tamiflu to prevent influenza in children aged one to 12 years. The neuraminidase inhibitor already is indicated to treat influenza in adults and chil...